Source: StreetInsider

Press Release: YAS Holding : Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH,...

Read full article »
YAS Holding's Competitors | YAS Holding's News | YAS Holding's Financials
Stay up-to-date with the latest news on YAS Holding
Est. Annual Revenue
$100-500M
Est. Employees
5.0-10K
Low Ping's photo - CEO of YAS Holding

CEO

Low Ping

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on YAS Holding